Clinitech Laboratory IPO: Price Band, Lot Size, Financials & Review
Clinitech Laboratory IPO listed on BSE on Thu, 1 Aug 2024. The issue was subscribed 38.96x overall.
- Open Date
- 25 Jul 2024
- Close Date
- 29 Jul 2024
Last updated
- Issue price
- ₹96
- Lot size
- 1,200 shares
- Min. investment
- ₹2,30,400
- Issue size
- ₹5.78 Cr
- Last GMP
- +₹65
- Subscribed
- 🔥 38.96x
Clinitech Laboratory IPO details
Clinitech Laboratory IPO is a ₹5.78 Cr iPO on the SME segment, listing on BSE. It is entirely a fresh issue of shares, so all the money raised goes to the company; there is no offer for sale by existing shareholders.
The issue was open from Thu, 25 Jul 2024 to Mon, 29 Jul 2024. Allotment was finalised on Tue, 30 Jul 2024, and the shares listed on BSE on Thu, 1 Aug 2024.
The issue price is ₹96 per share and the lot size is 1200 shares, so the minimum retail application is ₹2,30,400. Retail investors can apply for up to 1 lots (1,200 shares, ₹1,15,200).
Bigshare Services Pvt Ltd is the registrar, and Inventure Merchant Banker Services Pvt Ltd is the book running lead manager.
Grey market premium (GMP)
Day-wise GMP →The last Clinitech Laboratory IPO GMP before listing was +₹65 (+67.71% against the upper price band of ₹96), implying an estimated listing price of ₹161.
| Last GMP | +₹65 |
|---|---|
| GMP vs upper band | +67.71% |
| Estimated listing price | ₹161 |
Grey market trading is unofficial and unregulated. GMP is a sentiment indicator, not a guarantee of the listing price. See the Clinitech Laboratory IPO day-wise GMP.
Subscription
Day-wise subscription →Clinitech Laboratory IPO was subscribed 38.96x overall: retail 49.61x.
| Category | Subscribed |
|---|---|
| Retail | 49.61x |
| Others | 23.28x |
| Total | 38.96x |
Final figures at the close of bidding on 29 Jul 2024. Category-wise bids, application-wise breakup and allotment chances are on the Clinitech Laboratory IPO day-wise and category-wise subscription page.
Share reservation by category
| Category | Shares offered | Share of issue |
|---|---|---|
| Market Maker | 31,200 | 5.18% |
| Others | 2,85,600 | 47.41% |
| Retail Investors | 2,85,600 | 47.41% |
| Total | 6,02,400 | 100.00% |
Clinitech Laboratory IPO lot size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,15,200 |
| Retail (Max) | 1 | 1,200 | ₹1,15,200 |
| S-HNI (Min) | 2 | 2,400 | ₹2,30,400 |
Amounts at the upper end of the price band.
Issue structure and valuation
It is entirely a fresh issue of shares, so all the money raised goes to the company; there is no offer for sale by existing shareholders.
At the upper price band of ₹96, the issue is priced at 43.45x pre-issue earnings and 59.03x post-issue earnings per share.
The post-issue P/E is higher because the fresh issue adds new shares, which spreads the same profit over more shares.
Promoter holding falls from 83.63% before the issue to 61.56% after it.
| EPS (pre-issue) Latest earnings per share before the issue | ₹2.21 |
|---|---|
| P/E (pre-issue) Upper price band ÷ pre-issue EPS | 43.45x |
| EPS (post-issue) EPS on the enlarged share capital | ₹1.63 |
| P/E (post-issue) Upper price band ÷ post-issue EPS | 59.03x |
| Promoter holding (pre-issue) | 83.63% |
| Promoter holding (post-issue) | 61.56% |
Clinitech Laboratory Limited financials
Between 31 Mar 2023 and 31 Mar 2024, Income rose from ₹636.34 Cr to ₹643.92 Cr, and profit after tax fell from ₹61.31 Cr to ₹37.12 Cr. The PAT margin for 31 Mar 2024 was 5.76%.
| Period ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 560.79 | 603.33 | 368.74 | 273.32 |
| Total Income | 643.92 | 636.34 | 645.70 | 459.63 |
| Profit After Tax | 37.12 | 61.31 | 51.26 | 40.24 |
| Net Worth | 354.80 | 238.08 | 184.81 | 139.03 |
| Reserve & Surplus | 186.80 | 88.08 | 34.81 | 72.37 |
| Total Borrowings | 86.31 | 102.91 | 88.61 | 53.67 |
₹ in crore, as stated in the prospectus.
Key performance indicators
| KPI | |
|---|---|
| Debt / Equity | 0.24 |
| RoNW % | 10.46 |
| PbW | 4.55 |
| Pat Margin % | 5.76 |
Objectives
The company intends to allocate the net proceeds from the offering to the following objectives.
| Sr | Objective |
|---|---|
| 1 | Expansion of Diagnostic Centres. |
| 2 | General Corporate Purposes. |
About Clinitech Laboratory Limited
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.
The company performs more than 150 tests in its centres, which are divided into different categories: Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests and Histopathology Tests.
Clinitech Laboratory has eight diagnostic centres around Thane and Navi Mumbai. The company conducts more than 3 lakh tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratories equipped with modern technology and high quality equipment.
The company's medical testing facilities at Airoli, Navi Mumbai, have been accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) as per ISO 15189:2012.
As of May 31, 2024, the company employed 85 people in various departments.
Promoters
Jagdish Umakant Nayak, Jyoti Jagdish Nayak, and Ashutosh Jagdish Nayak
Clinitech Laboratory IPO FAQs
- What is the Clinitech Laboratory IPO price band?
- Clinitech Laboratory IPO is a fixed price issue at ₹96 per share.
- What is the Clinitech Laboratory IPO lot size and minimum investment?
- The Clinitech Laboratory IPO lot size is 1200 shares. The minimum retail investment is ₹2,30,400 for one lot at the upper price band. Retail investors can apply for up to 1 lots (1,200 shares), costing ₹1,15,200.
- When was Clinitech Laboratory IPO open for subscription?
- Clinitech Laboratory IPO was open for subscription from Thu, 25 Jul 2024 to Mon, 29 Jul 2024.
- What is the Clinitech Laboratory IPO subscription status?
- Clinitech Laboratory IPO was subscribed 38.96x overall: retail 49.61x. Day-wise and category-wise figures are on the subscription page.
- What was the Clinitech Laboratory IPO GMP before listing?
- The last Clinitech Laboratory IPO GMP before listing was +₹65 (+67.71% against the upper price band of ₹96), implying an estimated listing price of ₹161. GMP is an unofficial grey market indicator and can change quickly.
- What is the Clinitech Laboratory IPO allotment date?
- The Clinitech Laboratory IPO basis of allotment was finalised on Tue, 30 Jul 2024. You can check your allotment status on the Bigshare Services Pvt Ltd website.
- What is the Clinitech Laboratory IPO listing date?
- Clinitech Laboratory IPO listed on BSE on Thu, 1 Aug 2024.
- Is the Clinitech Laboratory IPO a fresh issue or an offer for sale?
- It is entirely a fresh issue of shares, so all the money raised goes to the company; there is no offer for sale by existing shareholders.
- Who are the registrar and lead managers of the Clinitech Laboratory IPO?
- The registrar for the Clinitech Laboratory IPO is Bigshare Services Pvt Ltd, and the book running lead manager is Inventure Merchant Banker Services Pvt Ltd.
Data is compiled from the prospectus, stock exchanges and market sources and is for information only. It is not investment advice; read the RHP before applying.